Results 81 to 90 of about 16,259 (167)

Population immunity to clade 2.3.4.4b H5N1 is dominated by anti-neuraminidase antibodies. [PDF]

open access: yesmBio
Singh G   +13 more
europepmc   +1 more source

Presswerk Köngen champions GMT

open access: yesReinforced Plastics, 1994
openaire   +1 more source

Serological responses to killed oral cholera vaccine (OCV) when given 4 years after initial receipt of OCV in Cameroon: A randomized controlled trial. [PDF]

open access: yesPLOS Glob Public Health
Ateudjieu J   +9 more
europepmc   +1 more source

Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years. [PDF]

open access: yesClin Infect Dis
Mitha E   +19 more
europepmc   +1 more source

SARS-CoV-2 Omicron infection reveals imprinted antibody responses in the absence of vaccination. [PDF]

open access: yesiScience
Abdullahi A   +36 more
europepmc   +1 more source

Predictive factors and clinical outcomes following contemporary percutaneous coronary interventions for chronic total occlusions. [PDF]

open access: yesFront Cardiovasc Med
Jin L   +7 more
europepmc   +1 more source

Population immunity, post-vaccine and post-infection antibody responses to influenza A (H3N2) subclade J.2 and K (J.2.4.1) viruses, Hong Kong, 2025. [PDF]

open access: yesEuro Surveill
Cheng SM   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy